Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | LDHB | P07195 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL2480100 | 0.94 | LMNA (0.60) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL30552142 | 0.94 | LMNA (0.60) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL8107234 | 0.94 | LMNA (0.60) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL1357085 | 0.91 | LMNA (0.56) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL28872893 | 0.91 | LMNA (0.56) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL6841403 | 0.86 | LMNA (0.50) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL5693484 | 0.85 | LMNA (0.56) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL6845440 | 0.85 | LMNA (0.48) | LMNAALDH1A1ACHEOR51E2SLC22A6 | |
| Glycerin SCHEMBL8328163 | 0.84 | LMNA (0.64) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL4538901 | 0.84 | LMNA (0.64) | LMNAALDH1A1OR51E2SLC22A6THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009091350-A1 | POLYCARBAMIDES, POLYCARBAMATES, AND POLYCARBAMIDE-FORMALDEHYDE AND POLYCARBAMATE-FORMALDEHYDE CONDENSATION RESINS | MISSISSIPPI STATE UNIVERSITY (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090149608-A1 | Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins | MISSISSIPPI STATE UNIVERSITY | 2009-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149608-A1 | Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins | SUV39H1, PFAS, SUV39H2 | LMNA 953/4885ALDH1A1 2009/4885ACHE 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.